Skip to main content
Debra Friedman, MD, Pediatric Hematology & Oncology, Nashville, TN

DebraFriedmanMD

Pediatric Hematology & Oncology Nashville, TN

Professor of Pediatrics and Medicine, Vanderbilt University Medical Center

Dr. Friedman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Friedman's full profile

Already have an account?

  • Office

    2525 West End Ave
    Suite 600
    Nashville, TN 37203
    Phone+1 615-322-4708
    Fax+1 615-936-8291

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1994 - 1997
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 1991 - 1994
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1991

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2008 - 2026
  • AL State Medical License
    AL State Medical License 2020 - 2020
  • WA State Medical License
    WA State Medical License 1998 - 2010
  • PA State Medical License
    PA State Medical License 1991 - 1998
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly
  • America's Top Doctors for Cancer Castle Connolly
  • Nashville Lifestyles Magazine Castle Connolly

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pericardial Effusion in Hodgkin Lymphoma: A Report from the Children's Oncology Group AHOD0031  
    Lianna J Marks, Debra L Friedman, Cindy L Schwartz, Kathleen McCarten, Blood

Press Mentions

  • Teleoncology Addresses Health Disparities with High Satisfaction for Patients and Providers, NCI Shares
    Teleoncology Addresses Health Disparities with High Satisfaction for Patients and Providers, NCI SharesMay 2nd, 2022
  • Telehealth-Based Cancer Care Surged During COVID. Will It Continue?
    Telehealth-Based Cancer Care Surged During COVID. Will It Continue?March 9th, 2022
  • Keeping Cancer Drugs from Causing Heart Damage
    Keeping Cancer Drugs from Causing Heart DamageMay 18th, 2016

Professional Memberships